Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company's operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive (CBRNE) detection products. The Bruker Nano segment desi... (Source: SEC reports)
Competitor - 1/7
Which company is more competitive with Bruker Daltonics?
BILLERICA, Mass., June 6, 2018 /PRNewswire/ --Â Bruker today announced that it has appointed Gerald N. Herman to serve as the Company\'s Chief Financial Officer (CFO), effective immediately. Â Mr. Herman [...]
BILLERICA, Mass., Feb. 21, 2018 /PRNewswire/ --Â Bruker Corporation (NASDAQ: BRKR) today announced that Mr. Anthony L. Mattacchione, Chief Financial Officer (CFO) and Senior Vice President of Bruker, [...]
BERLIN, Aug. 7, 2017 /PRNewswire/ --Â Bruker today announced that it has acquired XGLab S.r.l., a company that develops and manufactures analytical instruments for applications in the field of X-Ray spectrometry [...]
LEIPZIG, Germany, Aug. 2, 2017 /PRNewswire/ -- Bruker today announced the closing of a technology platform and product line acquisition to further expand its range of bacterial, viral and toxin detection solutions [...]
BILLERICA, Mass., May 12, 2017 /PRNewswire/ --Â Bruker Corporation (NASDAQ: BRKR) today announced that its Board of Directors has approved a new share repurchase program authorizing the purchase [...]